Literature DB >> 27356204

Current Status of Prostate Cancer Diagnosis and Management in the United States.

Matthew J Maurice1, Simon P Kim2, Robert Abouassaly2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27356204     DOI： 10.1001/jamaoncol.2016.1785

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  4 in total

1.  Overexpression of SOX4 induces up-regulation of miR-126 and miR-195 in LNCaP prostate cancer cell line.

Authors:  Nam Nhut Phan; Carlos S Moreno; Yu-Heng Lai
Journal:  Cytotechnology       Date:  2020-05-17       Impact factor: 2.058

2.  Associations of Medicaid Expansion With Insurance Coverage, Stage at Diagnosis, and Treatment Among Patients With Genitourinary Malignant Neoplasms.

Authors:  Katharine F Michel; Aleigha Spaulding; Ahmedin Jemal; K Robin Yabroff; Daniel J Lee; Xuesong Han
Journal:  JAMA Netw Open       Date:  2021-05-03

3.  Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the US.

Authors:  Vishesh Agrawal; Xiaoyue Ma; Jim C Hu; Christopher E Barbieri; Himanshu Nagar
Journal:  JAMA Netw Open       Date:  2020-08-03

4.  The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature.

Authors:  Arie Carneiro; Álan Roger Gomes Barbosa; Lucas Seiti Takemura; Paulo Priante Kayano; Natasha Kouvaleski Saviano Moran; Carolina Ko Chen; Marcelo Langer Wroclawski; Gustavo Caserta Lemos; Isabela Werneck da Cunha; Marcos Takeo Obara; Marcos Tobias-Machado; Adam G Sowalsky; Bianca Bianco
Journal:  Front Oncol       Date:  2018-09-18       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.